the Related Factors of Bariatric Surgery on Lipidemia

NCT03689803 | Unknown

• 1 other identifier: FirstJinanU20180214
• Study Type: interventional
• Target: 1,000
• Locations: 1 country
• Sites: 1

Brief Summary

Obesity and related metabolic diseases have become a chronic disease that is a threat to human health. Bariatric surgery can effectively and long-term reduce excess body weight and relieve related metabolic diseases, including type 2 diabetes. Laparoscopic gastric bypass surgery and laparoscopic sleeve gastrectomy are commonly used in bariatric surgery. Laparoscopic sleeve gastrectomy due to simple operation, good weight loss, and metabolic disease control effect, which is more widely used. However, there are several studies that show an increased chance of gastroesophageal reflux disease after laparoscopic sleeve gastrectomy. Long-term gastroesophageal reflux may lead to Barrett's esophagus or esophageal cancer. Nowadays, the cause of gastroesophageal reflux disease after sleeve gastrectomy is not clear and precautionary measures are not precise. In this study, prospective randomized controlled trials were conducted to explore the possible change of lipidemia after bariatric surgery and to explore ways to prevent bariatric surgery after bariatric surgery.

Conditions

Bariatric Surgery; Lipidemia

Outcome Measures

Primary Outcomes (4)

• preoperative of choleaterol

  choleaterol in ml/dl

  Preoperate

• Postoperative of choleaterol at 3 months

  choleaterol in ml/dl

  3 months

• Postoperative of choleaterol at 6 months

  choleaterol in ml/dl

  6 months

• Postoperative of choleaterol at 1 year

  choleaterol in ml/dl

  1 year

Secondary Outcomes (4)

• Preoperative of triglyceride

  Preoperative

• Postoperative of triglyceride at 3 months

  3 months

• Postoperative of triglyceride at 6 months

  6 months

• Postoperative of triglyceride at 1 year

  1 year

Study Arms (1)

Lipidemia

ACTIVE COMPARATOR

Procedure: sleeve gastrectomy; Procedure: gastric bypass

Interventions

sleeve gastrectomy PROCEDURE

sleeve gastrectomy.

Lipidemia

gastric bypass PROCEDURE

gastric bypass

Lipidemia

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• For the choice of surgical approach, numerous studies have shown that BMI ≧ 45, the general choice of gastric bypass surgery, BMI \<45, you can choose sleeve gastrectomy. The remission rate for T2DM, sleeve gastrectomy has a good result for young patients with shorter duration. In the investigator's country, the BMI less than 45 is majorities.

You may not qualify if:

• BMI\<27.5

Sponsors & Collaborators

• First Affiliated Hospital of Jinan University: lead

Study Sites (1)

The frist affiliated hospital of Jinan University

Guangzhou, Guangdong, 510630, China

Location

MeSH Terms

Conditions

Hyperlipidemias

Interventions

Gastric Bypass

Condition Hierarchy (Ancestors)

Dyslipidemias; Lipid Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Bariatric Surgery; Bariatrics; Obesity Management; Therapeutics; Gastroenterostomy; Anastomosis, Surgical; Surgical Procedures, Operative; Digestive System Surgical Procedures

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Director of bariatric surgery

Study Record Dates

• First Submitted: June 3, 2018
• First Posted: September 28, 2018
• Study Start: April 1, 2018
• Primary Completion: December 1, 2018
• Study Completion: December 1, 2019
• Last Updated: September 28, 2018

Record last verified: 2018-09

Locations

CN (1)